Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

Assessment of Exercise Intensity in Cardiac Rehabilitation Programmes for Patients With Chronic Heart Failure

6 mars 2012 uppdaterad av: Guy Lloyd

Cardiac rehabilitation is the ideal comprehensive intervention for patients with chronic heart failure (CHF), since it addresses the complex interplay of medical, psychological and behavioural factors facing these individuals. Structured exercise training within a cardiac rehabilitation programme is firmly recommended for these patients. However, it is questionable whether patients are achieving an adequate dose of exercise to provide optimal benefits. The essential components for setting optimal training include the appropriate mode, duration, frequency and intensity of exercise. UK surveys of cardiac rehabilitation describe the frequency and duration of training, but here is scant information on exercise intensity. However, it is apparent that randomised controlled trials of exercise training use doses more than 4 times greater than in UK current practice. The Eastbourne Exercise Cardiology Research Group has demonstrated that although patients benefit from improved quality of life and submaximal fitness after a hospital outpatient cardiac rehabilitation programme, they do not achieve the increases in important prognostic indicators reported by the majority of exercise training trials.

The critical factor in terms of eliciting a sufficient training effect while minimising risk is the intensity of the exercise performed. It is now widely accepted that the traditional methods of using fixed percentages of maximal heart rate or oxygen uptake to set exercise intensity include serious errors. The European Society of Cardiology recommends that cardiopulmonary exercise testing should be used to provide an objective evaluation of the metabolic demand of exercise. This allows physiologically meaningful reference points to be established for aerobic exercise prescription and is the solution to defining safe and effective training intensities. The next step is to determine whether this information can be transferred to a practical cardiac rehabilitation environment to set and monitor exercise intensity

Studieöversikt

Status

Okänd

Betingelser

Hjärtfel

Detaljerad beskrivning

Background Heart failure is a chronic, costly and life-threatening disorder that constitutes a significant burden for individuals and the National Health Service [There are 27,000 new cases reported per annum in the UK. Cardiac rehabilitation (CR) is recommended as the ideal comprehensive intervention since it addresses the complex interplay of medical, psychological and behavioural factors facing CHF patients and carers.

Study Aim Primary objective to describe the exercise intensity, defined by oxygen uptake (VO2) in terms of the individual physiological thresholds, in CHF patients undergoing CR according to current guidelines Primary end point: VO2 Secondary objectives Secondary objectives of this study are:-

To measure resting and exercising energy expenditure in order to a) establish the value of 1 MET (resting metabolic rate) for patients with CHF, and b) to establish the MET value (defined as multiples of resting metabolic rate) for exercises performed in CR sessions
To measure affective responses (feeling very bad - feeling very good; levels of energy - tiredness and tension - calmness) to exercise during CR sessions
To measure weekly physical activity level in CHF patients undergoing Phase III and IV CR.

For the secondary analysis the following secondary end points and parameters will be established

MET values, defined as multiples of resting oxygen uptake or resting metabolic rate (1 MET), for different CR exercises
Ratings of affective response on the Feelings Scale (FS) and ratings of perceived activation on the Felt Arousal Scale (FAS).
Average daily activity over 7 day period in terms of steps per day and periods spent sitting, standing and walking

Studietyp

Observationell

Inskrivning (Förväntat)

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studieorter

Storbritannien
- East Sussex
  - Eastbourne, East Sussex, Storbritannien, BN21 2UD
    - Eastbourne General Hospital

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

18 år och äldre (Vuxen, Äldre vuxen)

Tar emot friska volontärer

Nej

Kön som är behöriga för studier

Allt

Testmetod

Sannolikhetsprov

Studera befolkning

21 CHF patients from Heart Failure clinic at Eastbourne District General Hospital

Beskrivning

Inclusion criteria:

Systolic heart failure with resting left ventricular ejection fraction below 40%
New York Heart Association (NYHA) class I-III
clinically stable for at least 4 weeks on optimised medication dosage according to current guidelines

Exclusion criteria:

Acute coronary syndrome within past 6 months
Untreated lifethreatening cardiac arrhythmias
Acute heart failure (during initial period of haemodynamic instability)
Uncontrolled hypertension
Advanced atrioventricular block
Acute myocarditis or pericarditis
Symptomatic aortic stenosis
Severe hypertrophic obstructive cardiomyopathy
Acute systemic illness Intracardiac thrombus
Progressive worsening of exercise tolerance of dyspnoea at rest over previous 35 days
Significant ischaemia during low intensity exercise (< 2 METS, < 50W)
Uncontrolled diabetes
Recent embolism
Thrombophlebitis
New onset atrial fibrillation/flutter
> 1.8 kg increase in body mass over previous 13 days
Concurrent, continuous or intermittent dobutamine therapy
Decrease in systolic blood pressure with exercise
NYHA Functional Class IV
Complex ventricular arrhythmia at rest or appearing with exertion
Supine resting heart rate > 100 beats/min
Patient is participating in a conflicting study, is unable to perform exercise testing
Patient lacks the capacity to consent or cannot comply with study requirements

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

Vad mäter studien?

Primära resultatmått

Resultatmått	Tidsram
The primary outcome measure is the oxygen uptake(VO2)during exercise Tidsram: 13 weeks	13 weeks

Sekundära resultatmått

Resultatmått	Åtgärdsbeskrivning	Tidsram
Affective responses (e.g. feelings of pleasure/displeasure) Tidsram: 13 weeks	Questionnaire used to measure affective responses (Feelings Scale, Felt Anxiety Scale and Activation/Deactivation )	13 weeks
Weekly physical activity Tidsram: 13 weeks	Average daily physical activity: Participants' freeliving activity will be classified by ActivPAL into periods spent sitting, standing and walking, and daily energy expenditure will also be estimated from this information.	13 weeks

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Sponsor

Guy Lloyd

Utredare

Huvudutredare: Guy W Lloyd, MD, Eastbourne General Hospital

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart

1 april 2012

Primärt slutförande (Förväntat)

1 april 2013

Avslutad studie (Förväntat)